Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[2.]
I.D. Schwatz, A.W. Root.
The Klinefelter syndrome of testicular dysgenesis.
Endocrinol Metab Clin North Am, 20 (1991), pp. 153-163
[3.]
P. Kumanov.
Increased prolactin secretion and thyrotrophin response to thyrotrophin releasing hormone in Klinefelter's syndrome.
Andrologia, 27 (1995), pp. 41-45
[4.]
A.C. Pino, M.A. Czepielewski, I.L. Gross, W. Mossio, A.M. Lengyel.
A prolactin-secreting tumor in a patient with Klinefelter's syndrome: A case report.
J Endodrinol Invest, 19 (1996), pp. 248-252
[5.]
O. Serri, D. Noiseux, F. Robert, J. Hardy.
Lactotroph hyperplasia in an estrogen treated male-to-female transsexual patient.
J Clin Endocrinol Metab, 81 (1996), pp. 3177-3179
[6.]
Z. Dickerman, A. Rachmel, I. Gil-Ad, R. Prager-Lewin, A. Galatzer, Z. Lazon.
Rise in plasma growth hormone in response to exogenous LRH in Klinefelter's syndrome.
Clin Endocrinol, 15 (1981), pp. 403-410
[7.]
D.K. Sarkar, P.E. Gottschall, J. Meites.
Damage to hypothalamic dopaminergic neurons is associated with development of prolactin-secreting pituitary tumors.
Science, 218 (1982), pp. 684-686
[8.]
B. Magrini, J.R. Ebiner, P. Burckhardt, J.P. Felber.
Study on the relationship between plasma prolactin levels and androgen metabolism.
J Clin Endocrinol Metab, 43 (1976), pp. 944-947
[9.]
J.C. Prior, T.A. Cox, D. Fairholm, E. Kostashuk, R. Nugent.
Testosteronerelated exacerbation of a prolactin-producing macroadenoma: possible role for estrogen.
J Clin Endocrinol Metab, 64 (1987), pp. 391-394
Copyright © 2002. Sociedad Española de Endocrinología y Nutrición